An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.

Genetic mutations of FUS have been linked to many diseases including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration. A primate specific and polymorphic retrotransposon of the SINE-VNTR-Alu (SVA) family is present upstream of the FUS gene. Here we have demonstrated that thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Abigail L Savage, Thomas P Wilm, Kejhal Khursheed, Aleksey Shatunov, Karen E Morrison, Pamela J Shaw, Christopher E Shaw, Bradley Smith, Gerome Breen, Ammar Al-Chalabi, Diana Moss, Vivien J Bubb, John P Quinn
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/042fd4e948994b3b8766b4695db23620
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:042fd4e948994b3b8766b4695db23620
record_format dspace
spelling oai:doaj.org-article:042fd4e948994b3b8766b4695db236202021-11-18T08:29:08ZAn evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.1932-620310.1371/journal.pone.0090833https://doaj.org/article/042fd4e948994b3b8766b4695db236202014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24608899/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Genetic mutations of FUS have been linked to many diseases including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration. A primate specific and polymorphic retrotransposon of the SINE-VNTR-Alu (SVA) family is present upstream of the FUS gene. Here we have demonstrated that this retrotransposon can act as a classical transcriptional regulatory domain in the context of a reporter gene construct both in vitro in the human SK-N-AS neuroblastoma cell line and in vivo in a chick embryo model. We have also demonstrated that the SVA is composed of multiple distinct regulatory domains, one of which is a variable number tandem repeat (VNTR). The ability of the SVA and its component parts to direct reporter gene expression supported a hypothesis that this region could direct differential FUS expression in vivo. The SVA may therefore contribute to the modulation of FUS expression exhibited in and associated with neurological disorders including ALS where FUS regulation may be an important parameter in progression of the disease. As VNTRs are often clinical associates for disease progression we determined the extent of polymorphism within the SVA. In total 2 variants of the SVA were identified based within a central VNTR. Preliminary analysis addressed the association of these SVA variants within a small sporadic ALS cohort but did not reach statistical significance, although we did not include other parameters such as SNPs within the SVA or an environmental factor in this analysis. The latter may be particularly important as the transcriptional and epigenetic properties of the SVA are likely to be directed by the environment of the cell.Abigail L SavageThomas P WilmKejhal KhursheedAleksey ShatunovKaren E MorrisonPamela J ShawChristopher E ShawBradley SmithGerome BreenAmmar Al-ChalabiDiana MossVivien J BubbJohn P QuinnPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e90833 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Abigail L Savage
Thomas P Wilm
Kejhal Khursheed
Aleksey Shatunov
Karen E Morrison
Pamela J Shaw
Christopher E Shaw
Bradley Smith
Gerome Breen
Ammar Al-Chalabi
Diana Moss
Vivien J Bubb
John P Quinn
An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.
description Genetic mutations of FUS have been linked to many diseases including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration. A primate specific and polymorphic retrotransposon of the SINE-VNTR-Alu (SVA) family is present upstream of the FUS gene. Here we have demonstrated that this retrotransposon can act as a classical transcriptional regulatory domain in the context of a reporter gene construct both in vitro in the human SK-N-AS neuroblastoma cell line and in vivo in a chick embryo model. We have also demonstrated that the SVA is composed of multiple distinct regulatory domains, one of which is a variable number tandem repeat (VNTR). The ability of the SVA and its component parts to direct reporter gene expression supported a hypothesis that this region could direct differential FUS expression in vivo. The SVA may therefore contribute to the modulation of FUS expression exhibited in and associated with neurological disorders including ALS where FUS regulation may be an important parameter in progression of the disease. As VNTRs are often clinical associates for disease progression we determined the extent of polymorphism within the SVA. In total 2 variants of the SVA were identified based within a central VNTR. Preliminary analysis addressed the association of these SVA variants within a small sporadic ALS cohort but did not reach statistical significance, although we did not include other parameters such as SNPs within the SVA or an environmental factor in this analysis. The latter may be particularly important as the transcriptional and epigenetic properties of the SVA are likely to be directed by the environment of the cell.
format article
author Abigail L Savage
Thomas P Wilm
Kejhal Khursheed
Aleksey Shatunov
Karen E Morrison
Pamela J Shaw
Christopher E Shaw
Bradley Smith
Gerome Breen
Ammar Al-Chalabi
Diana Moss
Vivien J Bubb
John P Quinn
author_facet Abigail L Savage
Thomas P Wilm
Kejhal Khursheed
Aleksey Shatunov
Karen E Morrison
Pamela J Shaw
Christopher E Shaw
Bradley Smith
Gerome Breen
Ammar Al-Chalabi
Diana Moss
Vivien J Bubb
John P Quinn
author_sort Abigail L Savage
title An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.
title_short An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.
title_full An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.
title_fullStr An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.
title_full_unstemmed An evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALS.
title_sort evaluation of a sva retrotransposon in the fus promoter as a transcriptional regulator and its association to als.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/042fd4e948994b3b8766b4695db23620
work_keys_str_mv AT abigaillsavage anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT thomaspwilm anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT kejhalkhursheed anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT alekseyshatunov anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT karenemorrison anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT pamelajshaw anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT christophereshaw anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT bradleysmith anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT geromebreen anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT ammaralchalabi anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT dianamoss anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT vivienjbubb anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT johnpquinn anevaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT abigaillsavage evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT thomaspwilm evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT kejhalkhursheed evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT alekseyshatunov evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT karenemorrison evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT pamelajshaw evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT christophereshaw evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT bradleysmith evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT geromebreen evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT ammaralchalabi evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT dianamoss evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT vivienjbubb evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
AT johnpquinn evaluationofasvaretrotransposoninthefuspromoterasatranscriptionalregulatoranditsassociationtoals
_version_ 1718421722179305472